Your browser doesn't support javascript.
loading
Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD.
Bader, Cameron S; Pavlova, Anna; Lowsky, Robert; Muffly, Lori S; Shiraz, Parveen; Arai, Sally; Johnston, Laura J; Rezvani, Andrew R; Weng, Wen-Kai; Miklos, David B; Frank, Matthew J; Tamaresis, John S; Agrawal, Vaibhav; Bharadwaj, Sushma; Sidana, Surbhi; Shizuru, Judith A; Fernhoff, Nathaniel B; Putnam, Amy; Killian, Scott; Xie, Bryan J; Negrin, Robert S; Meyer, Everett H.
Afiliação
  • Bader CS; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Pavlova A; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Lowsky R; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Muffly LS; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA.
  • Shiraz P; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Arai S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Johnston LJ; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Rezvani AR; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA.
  • Weng WK; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Miklos DB; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Frank MJ; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Tamaresis JS; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA.
  • Agrawal V; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Bharadwaj S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Sidana S; Biomedical Data Sciences, Stanford University, Stanford, CA.
  • Shizuru JA; Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope, Duarte, CA.
  • Fernhoff NB; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Putnam A; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Killian S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.
  • Xie BJ; Orca Biosystems, Inc, Menlo Park, CA.
  • Negrin RS; Orca Biosystems, Inc, Menlo Park, CA.
  • Meyer EH; Orca Biosystems, Inc, Menlo Park, CA.
Blood Adv ; 8(5): 1105-1115, 2024 Mar 12.
Article em En | MEDLINE | ID: mdl-38091578
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article